LEXX Earnings Lexaria Bioscience Corp.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–21 of 21
| Q3 2026 | 2026-05-31 | -0.21 | 2026-07-13 | 10-Q |
| Q2 2026 | 2026-02-28 | -0.13 | 2026-04-13 | 10-Q |
| Q1 2026 | 2025-11-30 | -0.07 | 2026-01-13 | 10-Q |
| FY 2025 | 2025-08-31 | -0.66 | 2025-11-28 | 10-K |
| Q3 2026 | 2025-05-31 | -0.53 | 2026-07-13 | 10-Q |
| Q2 2026 | 2025-02-28 | -0.32 | 2026-04-13 | 10-Q |
| Q1 2026 | 2024-11-30 | -0.16 | 2026-01-13 | 10-Q |
| FY 2025 | 2024-08-31 | -0.47 | 2025-11-28 | 10-K |
| Q3 2025 | 2024-05-31 | -0.32 | 2025-07-14 | 10-Q |
| Q2 2025 | 2024-02-29 | -0.18 | 2025-04-14 | 10-Q |
| Q1 2025 | 2023-11-30 | -0.13 | 2025-01-10 | 10-Q |
| FY 2024 | 2023-08-31 | -1.01 | 2024-11-26 | 10-K |
| Q3 2012 | 2012-07-31 | -0.02 | 2012-09-12 | 10-Q |
| Q2 2012 | 2012-04-30 | -0.02 | 2012-06-07 | 10-Q |
| Q1 2012 | 2012-01-31 | -0.01 | 2012-03-13 | 10-Q |
| FY 2011 | 2011-10-31 | -0.04 | 2012-01-30 | 10-K |
| Q3 2012 | 2011-07-31 | -0.04 | 2012-09-12 | 10-Q |
| Q2 2012 | 2011-04-30 | -0.02 | 2012-06-07 | 10-Q |
| Q1 2012 | 2011-01-31 | -0.01 | 2012-03-13 | 10-Q |
| FY 2011 | 2010-10-31 | -0.04 | 2012-01-30 | 10-K |
| Q3 2011 | 2010-07-31 | -0.04 | 2011-09-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.